New study reports activated B. infantis EVC001 improves health outcomes in preterm infants

(Coyne PR) The new study, Impact of probiotic B. infantis EVC001 on the gut microbiome, nosocomially acquired antibiotic resistance, and enteric inflammation in preterm infants reports probiotic supplementation with EVC001 substantially reduces inflammation, diaper rash and antibiotic use in preterm infants. The paper was published in Frontiers in Pediatrics.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news